ArticleOncogenesis2014

Kinome-wide screening of HER2+ breast cancer cells for molecules that mediate cell proliferation or sensitize cells to trastuzumab therapy.

V Lapin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.